Brief: China Resources Pharmaceutical Says HY Revenue For KPC Pharmaceuticals RMB3.77 Bln
Aug 30 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* HY REVENUE FOR KPC PHARMACEUTICALS RMB3.77 BILLION VERSUS
RMB4.23 BILLION
* HY NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS
RMB223.4
MILLION VERSUS RMB216.6 MILLION
Source text for Eikon: ID:nHKS2k473X
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million